These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16108967)

  • 1. The kidney, a cardiovascular risk marker, and a new target for therapy.
    de Zeeuw D; Hillege HL; de Jong PE
    Kidney Int Suppl; 2005 Sep; (98):S25-9. PubMed ID: 16108967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal disease: a common and a silent killer.
    de Zeeuw D
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S27-35. PubMed ID: 18580863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria in essential hypertension.
    Mimran A
    Clin Exp Hypertens; 1997; 19(5-6):753-67. PubMed ID: 9247753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.
    Lambers Heerspink HJ; Gansevoort RT
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1079-88. PubMed ID: 25887073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microalbuminuria. Signification and value].
    Marre M
    Presse Med; 1993 Jun; 22(23):1098-103. PubMed ID: 8415463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
    Mercier K; Smith H; Biederman J
    Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to abandon microalbuminuria?
    Ruggenenti P; Remuzzi G
    Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?
    de Zeeuw D
    Kidney Int Suppl; 2004 Nov; (92):S2-6. PubMed ID: 15485410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart and kidney: fatal twins?
    Ritz E
    Am J Med; 2006 May; 119(5 Suppl 1):S31-9. PubMed ID: 16563946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension.
    Ruilope LM; Lahera V; Alcázar JM; Praga M; Campo C; Rodicio JL
    J Hypertens Suppl; 1994 Jul; 12(4):S59-63. PubMed ID: 7965276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of microalbuminuria in chronic heart failure patients.
    van de Wal RM; Asselbergs FW; Plokker HW; Smilde TD; Lok D; van Veldhuisen DJ; van Gilst WH; Voors AA
    J Card Fail; 2005 Oct; 11(8):602-6. PubMed ID: 16230263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
    Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF;
    Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
    Bakris GL; Kuritzky L
    Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microalbuminuria--a new cardiovascular risk factor?].
    Eisenberger U; Huynh-Do U
    Ther Umsch; 2006 Sep; 63(9):565-8. PubMed ID: 17048169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of proteinuria with angiotensin receptor blockers.
    Galle J
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S36-43. PubMed ID: 18580865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.
    Venkat KK
    South Med J; 2004 Oct; 97(10):969-79. PubMed ID: 15558924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.